GE HealthCare

GE HealthCare is a global healthcare solutions company founded in 1892 and headquartered in the medical technology sector, with a workforce of approximately 54,000 employees and operations in more than 160 countries. It became an independent public company listed on Nasdaq on January 4, 2023, following its spin-off from General Electric. Annual revenue stands at $20.6 billion, and the company invests more than $5.1 billion each year in research and development and product investment.

The business is organised around four segments. Imaging supplies medical imaging equipment and more than 200 imaging software applications. Ultrasound delivers ultrasound imaging technology for clinicians. Patient Care Solutions provides monitoring and care delivery technology to hospitals. Pharmaceutical Diagnostics produces diagnostic agents and related solutions. Across these areas the company works in AI-powered healthcare software, intelligent medical devices and precision care technology.

Its equipment installed base exceeds 5 million units, and the company says its technologies touch more than 1 billion patients annually, from major medical centres worldwide to remote regions such as Greenland. More than 11,000 patents have been granted globally, reflecting a 130-year legacy of innovation. Stated priorities include improving hospital efficiency and clinical outcomes, closer partnership with customers, and more personalised and precise patient care.